Pulmonary Diseases Completed Phase 1 Trials for Moxifloxacin (DB00218)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01107054A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy VolunteersTreatment